Author:
Huang Jianmin,Kan Quancheng,Lan ,Zhao Xuan,Zhang Zhen,Yang Shuangning,Li Hong,Wang Liping,Xu Li,Cheng Zhe,Zhang Yi
Funder
National Natural Science Foundation of China
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference48 articles.
1. Changing epidemiology of small-cell lung cancer in the United States over the last 30years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J. Clin. Oncol.,2006
2. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer;Antonia;Clin. Cancer Res.,2006
3. Running in place: the 20th anniversary of the NCCN small cell lung cancer guidelines panel;Kalemkerian;J. Natl. Compr. Cancer Netw.,2015
4. Fruh, M., et al., Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2013. 24 Suppl 6: p. vi99–105.
5. Zhi, X., et al., [Chinese guidelines on the diagnosis and treatment of primary lung cancer (2011 version)]. Zhongguo Fei Ai Za Zhi, 2012. 15(12): p. 677–88.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献